WO1999064869A3 - Back pain diagnosis and apparatus for use therein - Google Patents
Back pain diagnosis and apparatus for use therein Download PDFInfo
- Publication number
- WO1999064869A3 WO1999064869A3 PCT/GB1999/001823 GB9901823W WO9964869A3 WO 1999064869 A3 WO1999064869 A3 WO 1999064869A3 GB 9901823 W GB9901823 W GB 9901823W WO 9964869 A3 WO9964869 A3 WO 9964869A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- back pain
- diagnosis
- low back
- processes
- sciatica
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU42797/99A AU4279799A (en) | 1998-06-09 | 1999-06-09 | Back pain diagnosis and apparatus for use therein |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9812290.6A GB9812290D0 (en) | 1998-06-09 | 1998-06-09 | Back pain diagnosis |
GB9812290.6 | 1998-06-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999064869A2 WO1999064869A2 (en) | 1999-12-16 |
WO1999064869A3 true WO1999064869A3 (en) | 2000-03-02 |
Family
ID=10833380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1999/001823 WO1999064869A2 (en) | 1998-06-09 | 1999-06-09 | Back pain diagnosis and apparatus for use therein |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU4279799A (en) |
GB (1) | GB9812290D0 (en) |
WO (1) | WO1999064869A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7452351B2 (en) | 2004-04-16 | 2008-11-18 | Kyphon Sarl | Spinal diagnostic methods and apparatus |
US7824390B2 (en) | 2004-04-16 | 2010-11-02 | Kyphon SÀRL | Spinal diagnostic methods and apparatus |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0132830A2 (en) * | 1983-07-25 | 1985-02-13 | EASTMAN KODAK COMPANY (a New Jersey corporation) | Dry analytical element for alkaline phosphatase assay |
DD226017A1 (en) * | 1984-06-27 | 1985-08-14 | Adw Ddr | TEST STRIPS FOR DETECTING LYSOCYM (EC 3.2.1.17) |
EP0277540A1 (en) * | 1987-01-23 | 1988-08-10 | Hoechst Aktiengesellschaft | Method for the determination of lysozyme activity |
EP0381450A2 (en) * | 1989-01-31 | 1990-08-08 | Hybritech Incorporated | Assay for bone alkaline phosphatase |
WO1992010760A1 (en) * | 1990-11-30 | 1992-06-25 | Monoclonetics International, Incorporated | Methods for the diagnosis of chronic lower back and cervical pain |
WO1993003377A1 (en) * | 1991-07-31 | 1993-02-18 | Ziltener Hermann J | Method for the detection of phosphotyrosine residues |
EP0741144A1 (en) * | 1994-11-11 | 1996-11-06 | International Reagents Corporation | Antiannexin-v monoclonal antibody, process for producing the same, and use therof |
-
1998
- 1998-06-09 GB GBGB9812290.6A patent/GB9812290D0/en not_active Ceased
-
1999
- 1999-06-09 AU AU42797/99A patent/AU4279799A/en not_active Abandoned
- 1999-06-09 WO PCT/GB1999/001823 patent/WO1999064869A2/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0132830A2 (en) * | 1983-07-25 | 1985-02-13 | EASTMAN KODAK COMPANY (a New Jersey corporation) | Dry analytical element for alkaline phosphatase assay |
DD226017A1 (en) * | 1984-06-27 | 1985-08-14 | Adw Ddr | TEST STRIPS FOR DETECTING LYSOCYM (EC 3.2.1.17) |
EP0277540A1 (en) * | 1987-01-23 | 1988-08-10 | Hoechst Aktiengesellschaft | Method for the determination of lysozyme activity |
EP0381450A2 (en) * | 1989-01-31 | 1990-08-08 | Hybritech Incorporated | Assay for bone alkaline phosphatase |
WO1992010760A1 (en) * | 1990-11-30 | 1992-06-25 | Monoclonetics International, Incorporated | Methods for the diagnosis of chronic lower back and cervical pain |
WO1993003377A1 (en) * | 1991-07-31 | 1993-02-18 | Ziltener Hermann J | Method for the detection of phosphotyrosine residues |
EP0741144A1 (en) * | 1994-11-11 | 1996-11-06 | International Reagents Corporation | Antiannexin-v monoclonal antibody, process for producing the same, and use therof |
Non-Patent Citations (5)
Title |
---|
CHEMICAL ABSTRACTS, Columbus, Ohio, US; XP002900782 * |
DATABASE WPI Derwent World Patents Index; XP002900781 * |
DATABASE WPI Derwent World Patents Index; XP002900783 * |
DATABASE WPI Derwent World Patents Index; XP002900784 * |
DATABASE WPI Derwent World Patents Index; XP002900785 * |
Also Published As
Publication number | Publication date |
---|---|
AU4279799A (en) | 1999-12-30 |
WO1999064869A2 (en) | 1999-12-16 |
GB9812290D0 (en) | 1998-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA199900349A1 (en) | CATALYTIC SUB-UNIT OF HUMAN TELOMERASE | |
MY129189A (en) | Prostaglandin agonists and their use to treat bone disorders | |
BRPI0410296A (en) | system and method for determining the efficacy of treatment of neurological disorders using electroencephalogram | |
WO1998033509A3 (en) | Useful properties of human lactoferrin and variants thereof | |
ATE284959T1 (en) | DISRUPTION OF THE BINDING OF THE PROTEINS MDM2 AND P53 AND CORRESPONDING THERAPEUTIC APPLICATION | |
IL125735A (en) | Pharmaceutical compositions for the treatment of glaucoma comprising an inhibitor of serine-threonine kinase, tyrosine kinase or protein tyrosine phosphatase or an actin-disrupting compound | |
WO2002074337A8 (en) | Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases | |
WO2003055443A3 (en) | Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma | |
CA2322311A1 (en) | Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors | |
DE69625691D1 (en) | ADMINISTRATION OF PEPTIDYLHETEROCYCLES FOR THE TREATMENT OF THROMBINE IN RELATED DISEASES | |
HUP9700603A3 (en) | Pharmaceutical preparation for the treatment of blood coagulation disorders | |
MX9704030A (en) | 2-heterocyclyloxy and thiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof. | |
AU6257798A (en) | Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase | |
MX9704037A (en) | 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof. | |
IL94278A0 (en) | 2-saccharine derivatives,their preparation and pharmaceutical compositions containing them | |
WO2002046384A3 (en) | Kinases and phosphatases sequences, and use thereof | |
IT1290781B1 (en) | ACTIVE THERAPEUTIC AGENT FOR THE TREATMENT OF NEURONAL DEGENERATIVE DISEASES. | |
MX9805506A (en) | Novel medical use of an ace-inhibitor for treatment of dyspeptic symptoms. | |
WO1999064869A3 (en) | Back pain diagnosis and apparatus for use therein | |
WO1999009199A3 (en) | Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor | |
IL111196A0 (en) | Peptides and pharmaceutical compositions comprising them | |
ID23184A (en) | SALES OF BPC PEPTIDES WITH ORGANOPROTECTIVE ACTIVITIES FOR THE PROCESS OF MAKING AND USING IT IN THERAPY | |
IL139144A0 (en) | Mycobacterial inhibitors | |
DE69739190D1 (en) | MEDICAMENT FOR THE TREATMENT OF OCULAR CRUSH DISEASES | |
AU2185000A (en) | Treatment of diseases involving cyst formation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |